Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Gross Profit 2017–2025
Aquestive Therapeutics Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Aquestive Therapeutics Inc. gross profit for the quarter ending March 31, 2026 was 11.0 M, a 116.59% increase year-over-year.
- Aquestive Therapeutics Inc. gross profit for the twelve months ending March 31, 2026 was 29.8 M, a 26.53% decrease year-over-year.
- Aquestive Therapeutics Inc. annual gross profit for 2025 was 26.0 M, a 34.52% decrease from 2024.
- Aquestive Therapeutics Inc. annual gross profit for 2024 was 39.7 M, a 33.40% increase from 2023.
- Aquestive Therapeutics Inc. annual gross profit for 2023 was 29.8 M, a 5.15% increase from 2022.
- Aquestive Therapeutics Inc. annual gross profit for 2022 was 28.3 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aquestive Therapeutics Inc. Gross Profit — FAQ
Aquestive Therapeutics Inc. (AQST) gross profit over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Aquestive Therapeutics Inc.'s gross profit?
Aquestive Therapeutics Inc. (AQST) reported gross profit of $26M for fiscal 2025.
Where can I see AQST's gross profit history?
The chart and table above show Aquestive Therapeutics Inc.'s gross profit by year and by quarter, including the growth rate.